These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15708744)

  • 1. Using imaging biomarkers to accelerate drug development and clinical trials.
    Pien HH; Fischman AJ; Thrall JH; Sorensen AG
    Drug Discov Today; 2005 Feb; 10(4):259-66. PubMed ID: 15708744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomedical imaging in the safety evaluation of new drugs.
    Wang YX; Yan SX
    Lab Anim; 2008 Oct; 42(4):433-41. PubMed ID: 18782821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging with SPECT as a tool for drug development.
    Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
    Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of treatment results with biological agents: is there a need for a new methodology?
    Begent RH
    J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of imaging in preclinical drug development.
    Vanderheyden JL
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):374-81. PubMed ID: 19834446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the cardiovascular system: seeing is believing.
    Borg TK; Stewart JA; Sutton MA
    Microsc Microanal; 2005 Jun; 11(3):189-99. PubMed ID: 16060971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging in drug development.
    Willmann JK; van Bruggen N; Dinkelborg LM; Gambhir SS
    Nat Rev Drug Discov; 2008 Jul; 7(7):591-607. PubMed ID: 18591980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality imaging of structure and function.
    Townsend DW
    Phys Med Biol; 2008 Feb; 53(4):R1-R39. PubMed ID: 18263942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of antiangiogenic agents.
    Rehman S; Jayson GC
    Oncologist; 2005 Feb; 10(2):92-103. PubMed ID: 15709211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
    Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
    Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography.
    Abramson RG; Mavi A; Cermik T; Basu S; Wehrli NE; Houseni M; Mishra S; Udupa J; Lakhani P; Maidment AD; Torigian DA; Alavi A
    Semin Nucl Med; 2007 May; 37(3):146-53. PubMed ID: 17418148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of molecular imaging in drug discovery and development.
    Hargreaves RJ
    Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical imaging in pharmaceutical clinical trials: what radiologists should know.
    Wang YX
    Clin Radiol; 2005 Oct; 60(10):1051-7. PubMed ID: 16179164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of in vivo imaging of the central nervous system for developing novel drugs.
    Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular imaging to quantify the evolution of cardiac diseases in clinical development.
    Klein GJ; Thirion JP
    Biomarkers; 2005 Nov; 10 Suppl 1():S1-9. PubMed ID: 16298906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging in drug discovery and development.
    Rudin M; Weissleder R
    Nat Rev Drug Discov; 2003 Feb; 2(2):123-31. PubMed ID: 12563303
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarkers in abdominal imaging.
    Van Beers BE; Vilgrain V
    Abdom Imaging; 2009 Nov; 34(6):663-7. PubMed ID: 19048336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging modalities for prostate cancer.
    Fütterer JJ; Barentsz J; Heijmijnk ST
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):923-37. PubMed ID: 19589032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature.
    Narendran R; Martinez D
    Synapse; 2008 Nov; 62(11):851-69. PubMed ID: 18720516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.